akhatri

MHRA Class 4 Medicines Defect Notification: Simvastatin 10mg Tablet (Crescent Pharma Ltd) Date issued: 03 July 2025 Drug Alert Number: EL(25)A/33 Crescent Pharma Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of simvastatin 10 mg Tablets distributed by Alliance Healthcare UK. DMRC reference [...]

The post MHRA Class 4 Medicines Defect Notification: Simvastatin 10mg Tablet (Crescent Pharma Ltd) appeared first on Community Pharmacy England.

Community Pharmacy England recently announced that consultation fees for the Hypertension Case-Finding Service (HCFS) and the Pharmacy Contraception Service (PCS) are to be included in the advance payments issued to pharmacy owners by the NHS Business Services Authority. The first service fee advance was received on 12 May (for activity completed in April 2025) and [...]

The post Service fee advances appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Omeprazole 20 mg/15 ml Oral Solution (Glenmark Pharmaceuticals Europe Ltd) Drug Alert Number: EL(25)A/30 Date issued: 30 June 2025 Glenmark Pharmaceuticals Europe Ltd is recalling a specific batch of Omeprazole Oral Solution as a precautionary measure due to an investigation following a customer complaint indicating precipitation and discoloration of the product [...]

The post MHRA Class 3 Medicines Recall: Omeprazole 20 mg/15 ml Oral Solution (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 July 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Betaxolol 0.25% eye drops 0.25ml unit dose preservative free Betoptic® 0.25% eye drops [...]

The post 3 products re-classified as special containers from July 2025 appeared first on Community Pharmacy England.

From July 2025, Category A reimbursement prices will be based on data from suppliers obtained under the Health Service Products (Provision and Disclosure of Information) Regulations 2018. This follows a transition period which took place over six financial quarters from April 2024 to the end of June 2025, with reimbursement prices determined using a variable [...]

The post Category A price-setting arrangements from July 2025 appeared first on Community Pharmacy England.